Short-Chained Oligo(Ethylene Oxide)-Functionalized Gold Nanoparticles: Realization Of Significant Protein Resistance by Riley, Kathryn R. et al.
Swarthmore College 
Works 
Chemistry & Biochemistry Faculty Works Chemistry & Biochemistry 
1-1-2018 
Short-Chained Oligo(Ethylene Oxide)-Functionalized Gold 
Nanoparticles: Realization Of Significant Protein Resistance 
Kathryn R. Riley 
Swarthmore College, kriley1@swarthmore.edu 
C. M. Sims 
I. T. Wood 
D. J. Vanderah 
M. L. Walker 
Follow this and additional works at: https://works.swarthmore.edu/fac-chemistry 
 Part of the Biochemistry Commons 
Let us know how access to these works benefits you 
 
Recommended Citation 
Kathryn R. Riley, C. M. Sims, I. T. Wood, D. J. Vanderah, and M. L. Walker. (2018). "Short-Chained 
Oligo(Ethylene Oxide)-Functionalized Gold Nanoparticles: Realization Of Significant Protein Resistance". 
Analytical And Bioanalytical Chemistry. Volume 410, Issue 1. 145-154. DOI: 10.1007/s00216-017-0704-0 
https://works.swarthmore.edu/fac-chemistry/237 
This work is brought to you for free and open access by . It has been accepted for inclusion in Chemistry & 
Biochemistry Faculty Works by an authorized administrator of Works. For more information, please contact 
myworks@swarthmore.edu. 
Short-Chained Oligo(ethylene oxide)-Functionalized Gold 
Nanoparticles: Realization of Significant Protein Resistance
Kathryn R. Rileya,c,*, Christopher M. Simsa,*, Imani T. Wooda,d, David J. Vanderaha,b, and 
Marlon L. Walkera,e,*
aMaterial Measurement Laboratory, National Institute of Standards and Technology (NIST), 
Gaithersburg, MD 20899, USA
bInstitute for Bioscience and Biotechnology Research (IBBR), NIST, Rockville, MD 20850, USA
Abstract
Protein corona formed on nanomaterial surfaces play an important role in the bioavailability and 
cellular uptake of nanomaterials. Modification of surfaces with oligoethylene glycols (OEG) are a 
common way to improve the resistivity of nanomaterials to protein adsorption. Short-chain 
ethylene oxide (EO) oligomers have been shown to improve the protein resistance of planar Au 
surfaces. We describe the application of these EO oligomers for improved protein resistance of 30 
nm spherical gold nanoparticles (AuNPs). Functionalized AuNPs were characterized using UV-Vis 
spectroscopy, dynamic light scattering (DLS), and zeta potential measurements. Capillary 
electrophoresis (CE) was used for separation and quantitation of AuNPs and AuNP-protein 
mixtures. Specifically, nonequilibrium capillary electrophoresis of equilibrium mixtures 
(NECEEM) was employed for the determination of equilibrium and rate constants for binding 
between citrate-stabilized AuNPs and two model proteins, lysozyme and fibrinogen. Semi-
quantitative CE analysis was carried out for mixtures of EO-functionalized AuNPs and proteins, 
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and results demonstrated a 2.5-fold to 10-fold increase in protein binding resistance to lysozyme 
depending on the AuNP surface functionalization and a 15-fold increase in protein binding 
resistance to fibrinogen for both EO oligomers examined in this study.
Keywords
protein corona; gold nanoparticles; ethylene oxide; binding constant; capillary electrophoresis; 
NECEEM
Introduction
The unique features of gold nanoparticles (AuNPs), including ease of preparation [1], 
tunable optical properties [2], and facile surface functionalization [3], have attracted 
considerable interest from the scientific community over the past few decades. These 
properties have enabled AuNPs to be harnessed for applications in many fields, including 
biology and medicine, where they have been used for bioimaging, diagnostic assays, 
molecular delivery, and photothermal therapy [4–7]. On exposure to biological fluids, 
AuNPs interact with various native proteins, often resulting in the formation of an adsorbed 
protein coating on the particle surface, referred to as a “protein corona” [8–12]. The 
formation of a protein corona can significantly alter the apparent properties of the initial 
particle (e.g. size, shape, charge) and can adversely affect ligand conjugation and 
biodistribution, potentially leading to altered immune responses and potential toxicity [13–
18]. As such, researchers have sought to develop methods to decrease protein binding to 
AuNP surfaces [19–25].
Surface modification with thiol compounds, which exploits the relatively strong Au-S bond 
to increase ligand stability, is the most common method of increasing the protein adsorption 
resistance of AuNPs [26]. While a variety of thiol compounds are available for AuNP 
surface functionalization, thiol-terminated polyethylene glycols (PEG-SHs) are amongst the 
most commonly used [22,27–29]. PEG-SHs easily form monolayers on Au surfaces, are 
hydrophilic, have low toxicity, and reduce adsorption of proteins [22,30]. Several studies 
have demonstrated the relationship between PEG molecular weight and surface coverage 
with the degree of protein resistance; in general, increasing the ligand surface coverage, 
especially with higher molecular weight (longer-chain) PEG ligands leads to increased 
resistance towards protein binding [31].
Planar Au surfaces modified with oligoethylene glycol (OEG), which are short-chain 
oligomers, have also been shown to resist protein binding at levels comparable to PEG 
[19,20,32–34]. In contrast to their PEG counterparts, OEG compounds have been shown to 
have maximum protein resistance with a surface coverage of approximately 55%, with 
increased surface coverage actually leading to reduced protein adsorption resistance [35–38]. 
This observation, along with findings that some PEG and OEG modified surfaces are not 
protein resistant, illustrates that the ethylene oxide (EO) motif common to both PEG and 
OEG compounds may not be the primary contributor to protein resistance [39,40]. Unlike 
PEG compounds, OEG compounds can adopt well-defined chemical structures, making 
them better suited for understanding the mechanisms behind their protein resistive nature 
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[41]. While the exact conditions have yet to be clarified, the molecular characteristics of 
OEG surfaces found to give rise to high protein resistance include uniform surface coverage, 
conformational mobility, relative systemic disorder, and high degree of hydration [40]. 
While the protein resistance of planar Au surfaces modified by short-chain OEG compounds 
has been intensely studied, the generation of protein resistance via surface functionalization 
of AuNPs by short-chain OEG compounds has received less attention [19,20,32–34,42]. 
Understanding how the protein-binding resistance of short-chain OEGs on planar Au 
surfaces compares to spherical AuNP surfaces has implications for the design of AuNPs in 
biomedical applications since the curved surface can induce different conformations of the 
adsorbates and therefore different protein affinity constants [20,33,34].
Protein-binding resistance can be quantified through determination of equilibrium and rate 
constants. Heterogeneous binding assays, in which either the nanoparticle or protein is 
affixed to a solid substrate, or homogeneous binding assays, in which both the nanoparticle 
and protein are allowed to interact in free solution, may be employed. Previous studies using 
heterogeneous binding assays have been reported, such as immobilization of AuNPs on 
planar surfaces for quantitative analysis of protein corona by surface plasmon resonance 
(SPR) [43,44]. However, to more fully understand the dynamics governing protein 
adsorption to AuNP surfaces, homogeneous binding assays are preferred to allow the species 
to interact in free solution without restricted movement. To this end, several homogeneous 
binding assays have been reported that utilize dynamic light scattering (DLS) [45], circular 
dichroism (CD) spectroscopy [46], and fluorescence-based assays [47,48] for quantitative 
and semi-quantitative analysis of protein corona. The present study uses capillary 
electrophoresis (CE) for evaluation of protein-AuNP binding under homogeneous binding 
conditions.
CE is a high efficiency and rapid separation technique that relies on differences in the 
charge-to-size ratio of analytes as the basis for separation. It has been extensively used for 
the separation of biomolecules [49–51] and more recently for nanoparticles [52–55]. Kinetic 
capillary electrophoresis (KCE) can be used for the determination of equilibrium and rate 
constants and may be carried out in several modes [49]. One mode, affinity capillary 
electrophoresis (ACE) has been previously used to determine nanoparticle-protein 
dissociation constants, Kd [23,56]. Other modes, like the well-established nonequilibrium 
capillary electrophoresis of equilibrium mixtures (NECEEM) technique [57–60], allow for 
the determination of both equilibrium (Kd) and rate (koff) constants in a single experimental 
run, assuming 1:1 binding stoichiometry (see Supporting Information). The dissociation 
constant, Kd, and unimolecular rate constant for protein-AuNP dissociation, koff, can be 
determined through peak integration and curve fitting of the electropherogram resulting from 
injection of a mixture containing unbound protein and unbound AuNPs in equilibrium with 
protein-bound AuNPs. NECEEM is typically employed for DNA- or small molecule-protein 
binding [61,62], but here we demonstrate its application for evaluation of nanoparticle-
protein binding.
Herein we describe the preparation and characterization of thiol-functionalized AuNPs, the 
application of NECEEM for the determination of protein affinity for citrate-stabilized 
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AuNPs, and the evaluation of the improved protein-binding resistance of thiol-functionalized 
AuNPs.
Experimental1
Reagents
Hydroxythiol herein, 1HT, (IUPAC: 21-mercapto-3,6,9,12,15,18-hexaoxahenicosanol) and 
hydroxydithiol herein, HD, (IUPAC: 19-(3′-mercaptopropanyl)-22-mercapto-3,6,9,12,15,18-
hexaoxado-cosan-1-ol) were previously synthesized and characterized (Fig S1) [40]. Citrate-
stabilized AuNPs (nanoXact, 30 nm nominal particle diameter, 50 mg/L Au in 2 mM citrate 
solution) were obtained from nanoComposix (San Diego, CA) and are herein referred to as 
cit-AuNPs. Ultrapure deionized water (H2O, 18.2 MΩ*cm) was produced by a Millipore 
(Darmstadt, Germany) Milli-Q UV Plus Type I water purification system. Tris 
(hydroxymethyl) amino methane (Tris, ≥ 99.9 %), glycine (Gly, ≥ 99.0 %), fibrinogen (Fb, 
65 % -85 % protein, from bovine plasma) and lysozyme (Lz, ≥ 90 %, from chicken egg 
white) were obtained from Sigma-Aldrich (St. Louis, MO). All chemicals were used as 
received without further purification.
Stock solutions of HT and HD were prepared to final concentrations of 2 mM in water. 
Lyophilized proteins were prepared to a stock concentration of 1 mg/mL in water. Tris-Gly 
buffer was prepared to a final concentration of 5 mM Tris and 500 mM Gly with an 
unadjusted pH of 7.6.
Gold nanoparticle sample preparation
Functionalization and Wash of AuNPs—AuNP solutions were combined with water, 
HT solution, or HD solution in a 1:1 volumetric ratio (1.4 mL total volume) and the resultant 
mixtures were vortexed for 30 s and allowed to incubate for a minimum of 40 h. After 
incubation, the AuNP solutions were centrifuged at 3,900g for 12 min using a MiniSpin Plus 
microcentrifuge (Eppendorf, Hamburg, Germany). The supernatant was removed and the 
AuNPs were reconstituted in H2O and vortexed for 30 s. The AuNPs were centrifuged a 
second time (at 3,900g for 12 min), the supernatant was removed, and the AuNPs were 
suspended in either H2O or Tris-Gly buffer to half of the original solution volume (0.7 mL) 
so that the final concentration of AuNPs was ≈ 50 mg/L (≈ 0.3 nM). The final solution was 
resuspended by vortexing for 30 s. AuNPs suspended in water are herein referred to as cit-
AuNPs, while AuNPs functionalized with HT or HD are herein referred to as HT-AuNPs 
and HD-AuNPs, respectively.
Pre-wash of AuNPs—To test if the initial citrate concentration hindered functionalization 
of the AuNPs with HT and HD, a pre-wash step was performed prior to incubation with the 
thiol ligands. In this step, 0.7 mL AuNPs were centrifuged at 3,900g for 12 min and the 
supernatant was discarded. Then, H2O or Tris-Gly buffer was added to a final volume of 0.7 
mL and the AuNPs were resuspended by vortexing for 30 s. Pre-washed AuNPs resuspended 
in H2O were then subjected to the functionalization and wash procedure described above. 
Pre-washed AuNPs resuspended in Tris-Gly buffer were used as control samples.
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Gold nanoparticle characterization
Instrumentation and Methodology—The pH of AuNP solutions was recorded with an 
Orion™ 2-Star pH Meter (Thermo Scientific, Waltham, MA) using an InLab® Semi-Micro 
Combination pH Electrode (Mettler Toledo, Columbus, OH). pH values are reported as the 
mean of four measurements ± one standard deviation (SD).
Dynamic Light Scattering (DLS) measurements were collected on a Zetasizer Nano ZS 
(Malvern Instruments, Westborough, MA) operated in 173° backscatter mode with a laser 
wavelength of 633 nm.
Zeta Potential (ZP) measurements were obtained on the same instrument using a palladium 
dip cell and applying the Smoluchowski equation; sample conductivity was measured during 
the ZP runs. The DLS measurement procedure followed NIST-NCL protocol PCC-1 [63] 
with the z-average diameter (dz), polydispersity index (PDI), ZP and suspension 
conductivity values reported as the mean of five measurements plus or minus one standard 
deviation.
UV-Vis absorbance measurements were collected in UV-transparent disposable plastic 
semimicro cuvettes (Brandtech, Essex, CT) with a 1 cm path length using a Lambda 750 
spectrophotometer (Perkin-Elmer, Waltham, MA). The spectrometer was a split-beam style 
equipped with an 8 + 8 cell changer and water-jacketed temperature control. All 
measurements were recorded at ≈ 23°C.
Transmission electron microscope (TEM) images were taken on a (FEI, Hillsboro, OR) 
Titan 80-300 analytical TEM operated at an accelerating voltage of 300 kV in bright-field 
mode using an Orius (Gatan, Pleasanton, CA) digital camera. Samples were prepared for 
TEM imaging by drop-casting the respective dispersions onto carbon-coated copper TEM 
grids (Ted Pella Inc., Redding, CA). Particle size analysis was manually performed using 
ImageJ and counting 210 particles for each sample.
Capillary electrophoresis
CE studies were performed on a Beckman Coulter P/ACE MDQ CE System with UV 
detection at 214 nm. UV detection of AuNPs may also be performed at 520 nm (where they 
exhibit a strong SPR band, however, detection at 214 nm provided increased analyte signal 
relative to 520 nm, with no added background signal. An uncoated, fused-silica capillary 
(Polymicro Technologies, Phoenix, AZ) was used for all CE experiments, with a length and 
inner diameter of 60.2 cm (50.0 cm from inlet to detector) and 75 μm, respectively. A 20 kV 
separation voltage was applied and samples were injected at 4 psi (≈ 27,500 Pa) for 10 sec 
(≈ 355 nL injection volume).
All samples were diluted to final concentration in Tris-Gly buffer. To prepare AuNP-protein 
mixtures, working stock solutions of protein were prepared at various concentrations in Tris-
Gly buffer, so that the final volume of protein added to AuNP solutions would be constant 
and therefore, the concentration of AuNPs would be the same. Then, protein and AuNPs 
were combined, the resulting mixtures were vortexed for 10 s, and incubated at 4°C for a 
minimum of 1h. AuNP-protein mixtures were vortexed for 10 s just prior to CE analysis.
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32 KARAT software was used for CE control and data analysis, including manual peak 
integration and determination of analyte migration times. These data were subsequently 
processed using Microsoft Excel to determine Kd, koff, and kon according to NECEEM 
theory (see Supporting Information).
Results and Discussion
Gold nanoparticle characterization
Excess citrate in AuNP suspensions can affect separation efficiency by CE [64]. Thus, 
preliminary experiments focused on optimizing the number of wash cycles required to 
minimize the citrate concentration while maintaining the integrity of the AuNP suspension. 
The stock AuNP solutions were subjected to one, two, or three wash cycles. Conductivity 
measurements were used to estimate the concentration of citrate remaining in the AuNP 
suspension after successive wash cycles (Fig S2). The suspension conductivity of the stock 
AuNPs was 0.5778 mS/cm ± 0.0040 mS/cm, which decreased to 0.0089 mS/cm ± 0.0006 
mS/cm, 0.0021 mS/cm ± 0.0002 mS/cm, and 0.0016 mS/cm ± 0.0001 mS/cm after each 
wash cycle. While the first wash cycle removed the vast majority of the citrate, it was clear 
that the second wash cycle also removed a significant amount of citrate. The differences 
between the second and third wash cycles were small, with the absolute values of the 
measurements approaching that of pure water at ambient levels of CO2 (≈ 0.001 mS/cm) 
[65]. The stock (unwashed) AuNPs had an absorption peak centered at 520 nm (Fig S3), 
characteristic of the SPR band of ~30 nm AuNPs, and the hydrodynamic diameter (dz) was 
31.0 nm ± 0.6 nm, with a monomodal distribution (PDI = 0.10 ± 0.02; Table S1). After one 
wash cycle, the integrity of the AuNP suspension was essentially the same as the stock 
suspension, with the magnitudes of the SPR band (qualitative estimate of AuNP 
concentration) [66] and DLS size distributions nearly identical (Fig S3). The second wash 
cycle resulted in slight aggregation of AuNPs (leading to a slight reduction in Au 
concentration, as seen from the reduced absorbance), and after the third wash cycle the 
AuNP suspension was fully compromised (low absorbance, high PDI; Table S1). These 
observations show that the third wash cycle was ineffective at removing additional citrate 
and caused significant aggregation and reduction in absorbance. Ultimately, two wash cycles 
were selected as optimal in the present study in order to remove the maximum amount of 
citrate without inducing significant AuNP aggregation.
Next, studies were performed to test if the Tris-Gly buffer used for NECEEM would 
influence the physicochemical properties of the AuNPs. Stock AuNPs were subjected to a 
single wash cycle and reconstituted in either H2O or Tris-Gly buffer. The UV-Vis spectrum 
of each AuNP suspension was nearly identical, with similar z-average diameters and 
monomodal size distributions (Fig S4, Table S2). Given the similarities in absorbance and 
size distribution, the Tris-Gly buffer had little impact on the characteristics of the AuNPs. 
Consequently, all further characterization data were performed on AuNPs suspended in Tris-
Gly buffer, with the “stock” AuNPs reconstituted in Tris-Gly buffer used as control samples.
To test if the initial citrate concentration hindered functionalization of the AuNPs by the 
thiol ligands, a pre-wash step was performed on the stock AuNP suspension prior to 
incubation with the HT and HD ligands (as described in the experimental section). From 
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earlier experiments (Figure S1), it was shown that this wash procedure removes most of the 
citrate from the solution. Thus, when exposed to the thiol ligands, the AuNPs that have been 
pre-washed before functionalization contain far less citrate than the stock AuNPs. Both pre-
washed and stock AuNPs were exposed to thiol solutions (HT and HD) and incubated for at 
least 40 h to induce surface functionalization. The investigated physicochemical properties 
of each of the four thiol-functionalized samples (pre-washed and unwashed HT- and HD-
AuNPs) were essentially identical, with the SPR bands of all samples having slight red shifts 
compared to the stock AuNPs (from 520 nm to 523 nm) and with negligible differences in 
the hydrodynamic diameter and zeta potential (Fig S5, Table S3). With no observable 
differences in the pre-washed and unwashed thiol-functionalized samples, all future 
experiments were conducted without a pre-wash step in order to minimize sample 
preparation time.
Prior to protein affinity analysis, the physicochemical properties of the various AuNPs were 
measured under the optimized preparation conditions, which included two wash cycles and 
final constitution in Tris-Gly buffer. Stock AuNPs reconstituted in Tris-Gly buffer were used 
as a control to be compared to citrate, HT, and HD functionalized AuNPs prepared using the 
optimized protocol. The SPR band of the control and cit-AuNPs had a maximum absorbance 
at 520 nm, as expected based on the manufacturer specifications (Fig 1). The SPR band of 
HT-AuNPs and HD-AuNPs was slightly red shifted to 523 nm, which illustrates their 
functionalization by the thiol ligands (Fig 1) [20,33]. Further, the DLS obtained z-average 
diameters of the HT-AuNPs and HD-AuNPs were ≈ 3 nm larger than the control and cit-
AUNPs and also had smaller PDIs, suggesting the AuNPs were successfully functionalized 
and that the ligands increased the particle stability (Table 1). The measured ZPs of the 
AuNPs were ≈ −40 mV (except the HD-AuNPs), which confirmed a negatively charged 
corona surrounding the NPs, presumably from residual citrate (or other negatively charged 
ions present in the Tris-Gly buffer; Table 1)). Interestingly, the ZP of the HD-AuNPs is −31 
mV ± 1 mV, significantly less negative than the other AuNPs, including the HT-AuNPs (−40 
mV ± 1 mV; Table 1)). Given the similarities of the HT and HD ligands, the underlying 
cause behind this change likely arises from differences in their chemical structures. While 
HT is a monothiol, HD is a dithiol, which could result in different packing densities and 
surface coverage when the ligands form monolayers on the AuNPs, as seen in previous work 
involving planar Au surfaces [40]. In previous studies, it was shown that HT did not attain 
the highest possible surface coverage on planar Au substrates, while HD filled almost all the 
possible Au occupancy sites [40]. A similar phenomenon is likely occurring in the present 
study with AuNPs; whereby the HT-AuNPs have fewer surface sites occupied by the thiol 
ligand making it possible for more citrate (or other negatively charged ions in solution) to 
access the surface and leading to a more negative ZP relative to HD-AuNPs. These 
measurements suggest that the AuNPs are functionalized by the thiol ligands, which induce 
differences in their physicochemical properties. Previous work and ZP measurements 
suggest that the nature of surface modification by the thiol ligands varies due to their 
chemical structures, which could strongly influence the interactions of the functionalized 
AuNPs with proteins.
TEM images of the AuNPs were also obtained to provide additional information on the 
various AuNPs (Fig S6). Size analysis of AuNPs (n = 210) resulted in respective average 
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particle diameters of 29.2 nm ± 2.5 nm (cit-AuNPs), 28.1 nm ± 2.5 nm (HT-AuNPs), and 
30.3 nm ± 2.9 nm (HD-AuNPs). These results are in strong agreement with both each other 
and the vendor-reported average particle diameter of 30.3 nm ± 2.7 nm. This suggests that 
the functionalization of the AuNPs with HT or HD does not alter their size or lead to particle 
aggregation. The images of the HT- and HD-AuNPs show that the functionalized particles 
dried on the TEM grids in a less dispersed manner compared to their cit-AuNPs 
counterparts, suggesting a modified particle surface. Higher magnification (Fig S7) reveals a 
thin (≈ 1.5 nm thick) carbonaceous layer on the surfaces of the HT- and HD-AuNPs. It is 
well-known that electron beam irradiation can induce the graphitization of carbon-based 
materials in the TEM [67], which would arise from irradiation of the thiol ligands in this 
particular case. These observations, in addition to the physicochemical characterizations 
described earlier (and the CE results to follow), support our assertion of the successful 
functionalization of the AuNPs by HT or HD.
Improved robustness of thiol-functionalized gold nanoparticles
During optimization of the sample preparation protocol, it was observed that HT- and HD-
AuNPs could be subjected to successive wash cycles without significant aggregation (Fig 
S3, Table 1). To further probe the apparent robustness of the functionalized AuNPs, HT- and 
HD-AuNPs were subjected to 9 successive wash cycles. After 9 cycles, neither of the 
functionalized AuNPs exhibited significant change in z-average diameter and the PDIs were 
below ≈ 0.150 with a monomodal size distribution (Fig 2, Table S4). In comparison, the cit-
AuNPs subjected to 3 wash cycles exhibited a multimodal size distribution and the PDI 
increased from 0.10 ± 0.02 to 0.46 ± 0.01. It was expected that removal of citrate would 
induce significant aggregation since citrate is added to AuNP suspensions as a stabilizing 
agent. Most notable was the tolerance of the thiol-functionalized AuNPs to successive 
washing, with minimal sample aggregation. This apparent stability of EO-functionalized 
AuNPs is consistent with other studies conducted with analogous ligands [20,34].
Determination of equilibrium and rate constants for cit-AuNPs using NECEEM
Before beginning affinity studies, CE conditions were optimized for distinguishing cit-, HT-, 
and HD-AuNPs. With a straightforward modification of previously reported buffer 
conditions for particle separations in CE [68], the optimal buffer for separation of the 
different AuNPs was a Tris-Gly buffer. Using this buffer, cit- and HT-AuNPs migrated at ≈ 
5.1 min while HD-AuNPs migrated at ≈ 4.2 min (Fig S8). Since the basis for separation by 
CE is size-to-charge ratio, the migration times are consistent with the observed zeta 
potentials. Given the similar size of all the AuNPs, the more positive HD-AuNPs (ζ ≈ −31 
mV) would migrate earlier than the more negative cit- and HT-AuNPs (ζ ≈ −39 mV) based 
on the migration principles of normal polarity mode in CE. Some peak broadening is 
observed for each AuNP under the optimized buffer conditions. Other reports in the 
literature have utilized surfactants, like sodium dodecyl sulfate (SDS), to improve peak 
efficiencies of AuNPs in CE [69,70]. However, to avoid the influence of added surfactant on 
nanoparticle-protein binding, additives were not used to achieve more narrow peaks.
In order to carry out NECEEM studies, protein titrations were performed to identify suitable 
concentration ranges of lysozyme and fibrinogen. For example, a single peak was observed 
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for cit-AuNPs alone at ≈ 5.1 min, but with the addition of increasing amounts of lysozyme 
up to 25 nM a second peak at earlier migration time (≈ 4.1 min) was observed (Fig 3). The 
second peak is attributed to protein-bound AuNPs, which are expected to migrate differently 
than the AuNPs alone due to the difference in size-to-charge ratio caused by the adsorbed 
protein. At lysozyme concentrations greater than 25 nM, only a single peak at ≈ 4.1 min was 
observed, suggesting that most of the AuNPs were bound (Fig 3). The addition of fibrinogen 
to cit-AuNPs resulted in similar changes although at lower fibrinogen concentrations 
(beginning at ≈ 1 nM; Fig S9), presumably due to its significantly larger size (≈ 340 kDa 
compared to ≈ 14 kDa for lysozyme).
Ultimately, affinity calculations were performed for AuNPs (≈ 0.3 nM) combined with 10 
nM, 15 nM, or 20 nM lysozyme and 1 nM, 2 nM, or 3 nM fibrinogen. Three replicate CE 
measurements were recorded at each concentration point and the entire experiment was 
performed in triplicate (with fresh sample preparation for each replicate). The dissociation 
constant, Kd, and the unimolecular rate constant for dissociation, koff, were determined for 
each replicate and the bimolecular rate constant for association, kon, was determined using 
the Kd and koff (see Supporting Information). All values are reported as the average (n = 27) 
and standard deviation. Currently developed NECEEM theory assumes a 1:1 binding 
stoichiometry. It is known that nanoparticle-protein binding does not follow straightforward 
1:1 stoichiometry, so the accuracy of equilibrium and kinetic values reported herein are 
limited by this theoretical assumption.
Results show that fibrinogen has slightly higher affinity than lysozyme for cit-AuNPs (Table 
2). Further, the kinetics for protein-AuNP association (kon) are about 5-fold faster for 
fibrinogen relative to lysozyme (Table 2). The higher affinity and faster association kinetics 
for fibrinogen relative to lysozyme are consistent with it being a larger, “sticky” plasma 
protein. The dissociation constant and kinetic constants for fibrinogen differ significantly 
from another report in the literature conducted with 17 nm AuNPs (Kd ≈ 0.5 μM, koff ≈ 
0.002 s−1, kon ≈ 4000 M−1s−1) [43]. However, these variations could be attributed to the 
smaller particle size and/or the assay used, where the previous study involved SPR analysis 
of AuNPs immobilized on a chip. SPR analysis has limitations related to the complexity of 
the sample matrix and it has further been shown that immobilization of one component in a 
binding assay (heterogeneous binding) can reduce the binding affinity [68]. In addition, the 
advantage of using a separation technology, like CE and NECEEM analysis, is that small 
changes in the AuNP sample due to protein adsorption can be detected based on observable 
changes in migration time. This allows for the analysis to be conducted at lower 
concentrations of protein (nanomolar range) compared to previous work (micromolar range).
Improved protein resistance of functionalized gold nanoparticles
Finally, protein titrations were performed with HT- and HD-AuNPs and compared to cit-
AuNPs. For both HT- and HD-AuNPs, a second peak was not observed in the 
electropherogram when increasing amounts of protein were added to the sample, so 
NECEEM calculations were unable to be performed. However, a qualitative analysis of the 
electropherograms still provided significant insight as to how the HT and HD ligands 
modified the protein-AuNP interaction. For HT-AuNPs, slight changes in migration time 
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were observed and for HD-AuNPs a declination of the AuNP peak was observed with no 
corresponding increase in a second peak.
For cit-AuNPs incubated with ≈ 1 nM fibrinogen, a protein-AuNP peak was observed at ≈ 4 
min in addition to the AuNP peak at ≈ 5 min. At a fibrinogen concentration of ≈ 50 nM, 
only the peak at ≈ 4 min was observed, suggesting all of the AuNPs (initial concentration ≈ 
0.3 nM) were bound (Fig 4). In contrast, the electropherograms of ≈ 25 nM fibrinogen with 
HT- and HD-AuNPs had only a slight decrease in signal of the AuNP peak and not until a 
concentration of ≈ 50 nM fibrinogen was a marked decrease in the HT- or HD-AuNP peak 
observed (Fig 4). Similarly, ≈ 10 nM lysozyme produced a second peak in the 
electropherogram for cit-AuNPs, but lysozyme concentrations up to ≈ 25 nM for HT-AuNPs 
and ≈ 100 nM for HD-AuNPs were required to observe any decrease in signal or change in 
migration time in the electropherogram (Fig 5). In fact, HT-AuNPs did not undergo a 
significant decline in signal until the lysozyme concentration exceeded 50 nM and HD-
AuNPs appeared relatively resistant to lysozyme adsorption up to 300 nM (Fig 5). Overall, 
based on the concentration at which a decline in signal or change in migration time was first 
observed, a 2.5-fold and 10-fold improvement in lysozyme binding resistance was observed 
for HT- and HD-AuNPs, respectively and a 15-fold improvement in fibrinogen binding 
resistance was observed for both HT- and HD-AuNPs when compared to cit-AuNPs. These 
improvements in protein binding resistance of EO-functionalized AuNPs are consistent with 
binding studies conducted with other variations of EO ligands [19,32,42,34]. Importantly, 
the observation that HD demonstrated greater protein-binding resistance compared to HT 
and related structural compounds is consistent with previous work conducted on planar gold 
surfaces [40].
Conclusions
We have demonstrated the functionalization of 30 nm citrate-stabilized AuNPs with short-
chain EO oligomers, as confirmed by UV-Vis, DLS, and zeta potential measurements. We 
have further demonstrated the successful application of NECEEM for determining protein-
AuNP equilibrium and rate constants for citrate-stabilized AuNPs. Semi-quantitative 
analysis of protein binding to HT- and HD-functionalized AuNPs reveals improvements in 
protein binding resistance (decreases in protein affinity) ranging from 2.5-fold to 15-fold. In 
summary, this work indicates that short-chain EO oligomers, which have previously shown 
improved protein-binding resistance on planar Au surfaces, have significant potential 
towards improving biocompatibility of spherical AuNPs. Future work that quantifies EO 
ligand surface coverage and explores the effect of particle size (and thereby curvature) on 
coverage is in progress. Further, improvements in CE separation efficiency are needed to 
determine protein binding affinities and kinetics for HT- and HD-AuNPs by NECEEM.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig 1. 
UV-Vis and DLS plots comparing the different preparations of AuNP suspensions, as 
labeled in each DLS plot and with colors corresponding to the UV-Vis spectra. All 
suspensions are constituted in Tris-Gly buffer and were prepared as detailed in the 
Experimental Section. The vertical dotted line on the UV-Vis plot highlights the λmax (520 
nm) of the stock AuNPs’ SPR band.
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Fig 2. 
DLS size distributions of (A) cit-AuNPs subjected to 3 centrifugation cycles, or (B) HT-
AuNPs, and (C) HD-AuNPs subjected to 9 centrifugation cycles.
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Fig 3. 
Vertically offset electropherograms of 1 nM cit-AuNPs titrated with lysozyme 
(concentrations as indicated above each electropherogram).
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Fig 4. 
Electropherograms comparing the effect of AuNP surface functionality on fibrinogen 
adsorption. AuNPs are as indicated in the upper right corner of the electropherograms and 
fibrinogen concentrations are as indicated in the figure legend.
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Fig 5. 
Electropherograms comparing the effect of AuNP surface functionality on lysozyme 
adsorption. AuNPs are as indicated in the upper right corner of the electropherograms and 
lysozyme concentrations are as indicated in the figure legend.
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Table 1
Characterization of gold nanoparticle suspensions.
Control cit-AuNPs HT-AuNPs HD-AuNPs
SPR
(λmax, nm) 520 520 523 523
Z-average size
(dz, nm) 32.8 ± 1.4 31.8 ± 0.1 35.7 ± 0.7 35.3 ± 1.1
Polydispersity Index
(PDI) 0.11 ± 0.01 0.24 ± 0.01 0.10 ± 0.01 0.10 ± 0.01
ζ
(mV) − 40 ± 1 − 39 ± 1 −40 ± 1 −31 ± 1
pH 7.5 ± 0.1 7.5 ± 0.1 7.6 ± 0.1 7.6 ± 0.1
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Table 2
Equilibrium and rate constants for protein adsorption on cit-AuNPs.
Protein Kd(× 10−9 M)
koff
(s−1)
kon
(× 106 M−1 s−1)
Fibrinogen 4.8 ± 2 0.011 ± 0.003 2.9 ± 2
Lysozyme 31. ± 10 0.015 ± 0.004 0.56 ± 0.3
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